New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
NovaBay Pharmaceuticals, Inc.
NBY
Shape
US Flag

AMEX

Unprofitable

Unprofitable

3M

Biotechnology

Next Earning date - 14 Nov 2024

3M

Biotechnology

Next Earning date - 14 Nov 2024

0.62USD
Shape-0.00 ( -0.30%)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

-96%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

96%

Quote Panel

Shape
Updated October 12, 2024
1W -10.10 % 1M 31.19 % 3M -71.16 % 1Y -95.32 %

Key Metrics

Shape
  • Market Cap

    3.04M


  • Shares Outstanding

    4.89M


  • Share in Float

    4.89M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    0.623


  • Average Volume

    2.65M


  • Beta

    0.75


  • Range

    0.36-14.35


  • Industry

    Biotechnology


  • Website

    https://novabay.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.25x

P/S Ratio

-1.17x

P/B Ratio

-3.3

Debt/Equity

-88.8%

Net Margin

$-76.0

EPS

How NBY compares to sector?

P/E Ratio

Relative Strength

Shape

NBY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$14M

Shape467%

2025-Revenue

$0.84

Shape38%

2025-EPS

$8M

Shape-620%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-3.50
vs -1.75

Q4.22

arrow
arrow

N/A

-4.33
vs -0.70

Q1.23

arrow
arrow

N/A

-0.85
vs -0.08

Q2.23

arrow
arrow

N/A

-1.27
vs -1.40

Q3.23

arrow
arrow

N/A

-0.37
vs -3.50

Q4.23

arrow
arrow

N/A

-33.22
vs -4.33

Q1.24

arrow
arrow

N/A

-4.90
vs -0.85

Q2.24

arrow
arrow

N/A

-1.37
vs -1.27

Q3.24

arrow
arrow

N/A

-0.30
vs -0.37

Q4.24

arrow
arrow

N/A

-0.19
vs -33.22

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+108%

3.8M  vs 1.8M

Q4.22

arrow
arrow

+38%

3.6M  vs 2.6M

Q1.23

arrow
arrow

+19%

3.1M  vs 2.6M

Q2.23

arrow
arrow

+51%

4.6M  vs 3M

Q3.23

arrow
arrow

-15%

3.3M  vs 3.8M

Q4.23

arrow
arrow

+2%

3.7M  vs 3.6M

Q1.24

arrow
arrow

-16%

2.6M  vs 3.1M

Q2.24

arrow
arrow

-48%

2.4M  vs 4.6M

Q3.24

arrow
arrow

-20%

2.6M  vs 3.3M

Q4.24

arrow
arrow

-15%

3.1M  vs 3.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-42%

-0.42
vs -0.14

Q4.22

arrow
arrow

-78%

-0.78
vs -0.42

Q1.23

arrow
arrow

-20%

-0.20
vs -0.78

Q2.23

arrow
arrow

-47%

-0.47
vs -0.20

Q3.23

arrow
arrow

-25%

-0.25
vs -0.47

Q4.23

arrow
arrow

-124%

-1.24
vs -0.25

Q1.24

arrow
arrow

-2009%

-20.09
vs -1.24

Q2.24

arrow
arrow

+257%

2.57
vs -20.09

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

19

19
vs 18

6%

Q3.22

arrow
arrow

17

17
vs 19

-11%

Q4.22

arrow
arrow

1

1
vs 17

-94%

Q1.23

arrow
arrow

2

2
vs 1

100%

Q2.23

arrow
arrow

1

1
vs 2

-50%

Q3.23

arrow
arrow

1

1
vs 1

NA

Q4.23

arrow
arrow

2

2
vs 1

100%

Q1.24

arrow
arrow

1

1
vs 2

-50%

Earnings Growth

Latest News